We have shown a significantly increased level of plasma Robo4 in patients deemed to have AKI, not only using the more conservative AKIN classification based on serum creatinine levels, but also employing the novel AKI plasma and urine biomarker, NGAL. This evidence concerns the gene LCN2 and acute kidney injury.